Ciampi A, Thiffault J, Sagman U
Montreal Childrens Hospital Research Institute, Quebec, Canada.
Comput Methods Programs Biomed. 1989 Dec;30(4):283-96. doi: 10.1016/0169-2607(89)90099-0.
The RECPAM methodology previously presented in part I (A. Ciampi et al., Comput. Methods Programs Biomed. 26 (1988) 239-256) is applied to the analysis of survival data on small cell carcinoma of the lung (SCCL). It is shown how RECPAM can help answer the following questions which occur frequently in the analysis of clinical data: Is it possible to find a classification of patients with a certain disease into distinct prognostic groups? Given a covariate of special interest, does it have an independent prognostic significance even after confounding is taken into account? Does the prognostic significance of a covariate of special interest vary across patient subgroups? For the SCCL data, a prognostic classification is obtained and the tumor marker LDH is treated as a variable of special interest. Many features of RECPAM are illustrated, including, among others, Forward and Backward (Pruning) Stopping Rules, treatment of missing data, and use of several dissimilarity measures.
先前在第一部分(A. 钱皮等人,《计算机方法与程序在生物医学中的应用》26 (1988) 239 - 256)中介绍的RECPAM方法被应用于分析肺小细胞癌(SCCL)的生存数据。展示了RECPAM如何有助于回答临床数据分析中经常出现的以下问题:是否有可能将患有某种疾病的患者分类为不同的预后组?给定一个特别感兴趣的协变量,即使在考虑了混杂因素之后,它是否具有独立的预后意义?特别感兴趣的协变量的预后意义在不同患者亚组中是否有所不同?对于SCCL数据,获得了一种预后分类,并将肿瘤标志物乳酸脱氢酶(LDH)作为特别感兴趣的变量进行处理。展示了RECPAM的许多特征,包括向前和向后(剪枝)停止规则、缺失数据的处理以及几种不同相似性度量的使用。